Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats (Q48221934)

9 February 2018

title

Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats (English)

1 reference

9 February 2018

1 reference

C K Park

1

1 reference

9 February 2018

J McCulloch

series ordinal

2

1 reference

9 February 2018

J K Kang

series ordinal

3

1 reference

9 February 2018

C R Choi

series ordinal

4

1 reference

9 February 2018

publication date

1 January 1994

1 reference

9 February 2018

published in

Acta Neurochirurgica

1 reference

9 February 2018

volume

127

1 reference

9 February 2018

issue

3-4

1 reference

9 February 2018

page(s)

220-226

1 reference

9 February 2018

Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01808770

Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01808770

Continuous nimodipine treatment attenuates cortical infarction in rats subjected to 24 hours of focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01808770

Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01808770

Redistribution of regional cerebral blood flow after glycerol infusion in acute cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01808770

Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01808770

Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01808770

The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01808770

Glutamate and the pathophysiology of hypoxic--ischemic brain damage

21 January 2018

1 reference

12 December 2020

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

1 reference

12 December 2020

The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat

1 reference

12 December 2020

Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion

1 reference

12 December 2020

Kynurenate inhibition of cell excitation decreases stroke size and deficits

1 reference

12 December 2020

Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia

1 reference

12 December 2020

Effect of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischaemia in the rat

1 reference

12 December 2020

Phencyclidine reduces postischemic neuronal necrosis in rat hippocampus without changing blood flow

1 reference

12 December 2020

Brain intracellular pH, blood flow, and blood--brain barrier differences with barbiturate and halothane anesthesia in the cat.

1 reference

12 December 2020

Cerebral circulatory and metabolic effects of hypotension produced by deep halothane anaesthesia

1 reference

12 December 2020

Differential effects of competitive and non-competitive N-methyl-D-aspartate antagonists on glucose use in the limbic system

1 reference

12 December 2020

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke

1 reference

12 December 2020

D-CPP-ene (SDZ EAA 494), a potent and competitive N-methyl-D-aspartate (NMDA) antagonist: effect on spontaneous activity and NMDA-induced depolarizations in the rat neocortical slice preparation, compared with other CPP derivatives and MK-801.

1 reference

12 December 2020

Dextromethorphan reduces neocortical ischemic neuronal damage in vivo

1 reference

12 December 2020

Kainic acid induced seizures: neurochemical and histopathological changes

1 reference

12 December 2020

Inhibition of excitatory neurotransmission with kynurenate reduces brain edema in neonatal anoxia

1 reference

12 December 2020

Brain edema factors: current state with particular reference to plasma constituents and glutamate

1 reference

12 December 2020

Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.

1 reference

12 December 2020

Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats

1 reference

12 December 2020

Efficacy of D-CPPene, a competitive N-methyl-D-aspartate antagonist in focal cerebral ischemia in the rat

1 reference

12 December 2020

Anesthetic effects on blood-brain barrier function during acute arterial hypertension

1 reference

12 December 2020

Excitatory amino acid receptors, oxido-reductive processes and brain oedema following transient ischaemia in gerbils

1 reference

12 December 2020

The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemia

1 reference

12 December 2020

Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia

1 reference

12 December 2020

Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use

1 reference

12 December 2020

Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia

1 reference

12 December 2020

N-methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01808770

1 reference

9 February 2018

1 reference

9 February 2018